165 related articles for article (PubMed ID: 12839994)
21. How Vav proteins discriminate the GTPases Rac1 and RhoA from Cdc42.
Movilla N; Dosil M; Zheng Y; Bustelo XR
Oncogene; 2001 Dec; 20(56):8057-65. PubMed ID: 11781818
[TBL] [Abstract][Full Text] [Related]
22. Proto-oncogene products Vav and c-Cbl are involved in the signal transduction through Grb2/Ash in hematopoietic cells.
Hanazono Y; Odai H; Sasaki K; Iwamatsu A; Yazaki Y; Hirai H
Acta Haematol; 1996; 95(3-4):236-42. PubMed ID: 8677749
[TBL] [Abstract][Full Text] [Related]
23. GEF at work: Vav in protruding filopodia.
Kranewitter WJ; Danninger C; Gimona M
Cell Motil Cytoskeleton; 2001 Jul; 49(3):154-60. PubMed ID: 11668584
[TBL] [Abstract][Full Text] [Related]
24. Cell growth and metastasis in pancreatic cancer: is Vav the Rho'd to activation?
Billadeau DD
Int J Gastrointest Cancer; 2002; 31(1-3):5-13. PubMed ID: 12622410
[TBL] [Abstract][Full Text] [Related]
25. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product.
Crespo P; Schuebel KE; Ostrom AA; Gutkind JS; Bustelo XR
Nature; 1997 Jan; 385(6612):169-72. PubMed ID: 8990121
[TBL] [Abstract][Full Text] [Related]
26. Vav1/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells.
Fujikawa K; Miletic AV; Alt FW; Faccio R; Brown T; Hoog J; Fredericks J; Nishi S; Mildiner S; Moores SL; Brugge J; Rosen FS; Swat W
J Exp Med; 2003 Nov; 198(10):1595-608. PubMed ID: 14623913
[TBL] [Abstract][Full Text] [Related]
27. [The role of vav protein in TCR-mediated signaling with MHC/peptide complexes leading to positive or negative selection of thymocytes].
Matuszyk J; Kałas W; Kozicki R; Strzadała L
Postepy Hig Med Dosw; 1999; 53(4):531-43. PubMed ID: 10544657
[TBL] [Abstract][Full Text] [Related]
28. Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs.
Margolis B; Hu P; Katzav S; Li W; Oliver JM; Ullrich A; Weiss A; Schlessinger J
Nature; 1992 Mar; 356(6364):71-4. PubMed ID: 1531699
[TBL] [Abstract][Full Text] [Related]
29. Vav links antigen-receptor signaling to the actin cytoskeleton.
Fischer KD; Tedford K; Penninger JM
Semin Immunol; 1998 Aug; 10(4):317-27. PubMed ID: 9695188
[TBL] [Abstract][Full Text] [Related]
30. Vav regulates activation of Rac but not Cdc42 during FcgammaR-mediated phagocytosis.
Patel JC; Hall A; Caron E
Mol Biol Cell; 2002 Apr; 13(4):1215-26. PubMed ID: 11950933
[TBL] [Abstract][Full Text] [Related]
31. Essential role of Vav family guanine nucleotide exchange factors in EphA receptor-mediated angiogenesis.
Hunter SG; Zhuang G; Brantley-Sieders D; Swat W; Cowan CW; Chen J
Mol Cell Biol; 2006 Jul; 26(13):4830-42. PubMed ID: 16782872
[TBL] [Abstract][Full Text] [Related]
32. EGF receptor mediates adhesion-dependent activation of the Rac GTPase: a role for phosphatidylinositol 3-kinase and Vav2.
Marcoux N; Vuori K
Oncogene; 2003 Sep; 22(38):6100-6. PubMed ID: 12955089
[TBL] [Abstract][Full Text] [Related]
33. Vav cooperates with Ras to transform rodent fibroblasts but is not a Ras GDP/GTP exchange factor.
Bustelo XR; Suen KL; Leftheris K; Meyers CA; Barbacid M
Oncogene; 1994 Aug; 9(8):2405-13. PubMed ID: 8036025
[TBL] [Abstract][Full Text] [Related]
34. Vav GEFs are required for beta2 integrin-dependent functions of neutrophils.
Gakidis MA; Cullere X; Olson T; Wilsbacher JL; Zhang B; Moores SL; Ley K; Swat W; Mayadas T; Brugge JS
J Cell Biol; 2004 Jul; 166(2):273-82. PubMed ID: 15249579
[TBL] [Abstract][Full Text] [Related]
35. Tyrosine phosphorylation of RalGDS by c-Met receptor blocks its interaction with Ras.
Wong R; Feig LA
Biochem Biophys Res Commun; 2016 Nov; 480(3):468-473. PubMed ID: 27773821
[TBL] [Abstract][Full Text] [Related]
36. Vav binds to several SH2/SH3 containing proteins in activated lymphocytes.
Ramos-Morales F; Druker BJ; Fischer S
Oncogene; 1994 Jul; 9(7):1917-23. PubMed ID: 8208538
[TBL] [Abstract][Full Text] [Related]
37. Nuclear association of tyrosine-phosphorylated Vav to phospholipase C-gamma1 and phosphoinositide 3-kinase during granulocytic differentiation of HL-60 cells.
Bertagnolo V; Marchisio M; Volinia S; Caramelli E; Capitani S
FEBS Lett; 1998 Dec; 441(3):480-4. PubMed ID: 9891995
[TBL] [Abstract][Full Text] [Related]
38. Molecular analysis of Ras activation by tyrosine phosphorylated Vav.
Gulbins E; Schlottmann K; Brenner B; Lang F; Coggeshall KM
Biochem Biophys Res Commun; 1995 Dec; 217(3):876-85. PubMed ID: 8554611
[TBL] [Abstract][Full Text] [Related]
39. Vav proteins, masters of the world of cytoskeleton organization.
Hornstein I; Alcover A; Katzav S
Cell Signal; 2004 Jan; 16(1):1-11. PubMed ID: 14607270
[TBL] [Abstract][Full Text] [Related]
40. Differential motility of p190bcr-abl- and p210bcr-abl-expressing cells: respective roles of Vav and Bcr-Abl GEFs.
Daubon T; Chasseriau J; El Ali A; Rivet J; Kitzis A; Constantin B; Bourmeyster N
Oncogene; 2008 Apr; 27(19):2673-85. PubMed ID: 18059343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
